| Revenue Increases nearly twenty-fold over third Quarter of 2010 KENNESAW, Ga., Oct. 26, 2011 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the third quarter and nine months ended September 30, 2011. The Company recorded record revenue for the quarter of $2,152,000, a 12% percent increase over second quarter ...continued MDXG Orthopedic Prosthetic Healthcare |
Wednesday, October 26, 2011
MiMedx Group Announces Third Quarter 2011 Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment